Papers

3

Total Citations

50

H-Index

3

About

Dr. Zheng Jian Li is a pioneering researcher at the intersection of artificial intelligence, automation, and chemical engineering, with a primary focus on revolutionizing nanomaterial synthesis and biologics development. His most impactful contribution is the development of a chemical autonomous robotic platform that integrates AI decision modules with automated experiments, enabling end-to-end synthesis of nanoparticles. This breakthrough directly addresses the inefficiencies and instability of traditional trial-and-error methods, offering a data-driven pathway to reproducible, high-throughput nanomaterial production. With 23 citations since 2025, this work is rapidly gaining recognition as a transformative approach in materials science. Dr. Li also introduced "Process Analytics 4.0," a paradigm shift in rapid analytics for biologics development, which expands the analytical toolbox to keep pace with complex therapeutic modalities. His earlier work on adapting pore diffusion models for multi-addition batch uptake experiments (11 citations) demonstrates a sustained commitment to advancing bioprocess modeling. Through these innovations, Dr. Li is shaping a future where autonomous systems accelerate discovery and quality control in both nanomaterials and biopharmaceuticals.

Research Focus

Key Achievements

3
H-Index
3
Papers
50
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
A chemical autonomous robotic platform for end-to-end synthesis of nanoparticles
23 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: South China University of Technology, Bristol-Myers Squibb (Germany), Bristol-Myers Squibb (United States)

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago